Evaluation of the Safety and Efficacy of Parecoxib in Patients With Subarachnoid Hemorrhage

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

July 1, 2027

Conditions
Neurological Complication
Interventions
DRUG

Parecoxib

Parecoxib (Dynastat) 40 mg solution for injection is for intravenous administration. Parecoxib may be given as an intravenous injection for 30 minutes directly into a vein or through an intravenous infusion set.

DRUG

Placebo

Placebo intravenous injection can be administered quickly and directly into a vein or through an intravenous infusion set.

Trial Locations (1)

602 00

St. Anne's University Hospital Brno, Brno

All Listed Sponsors
collaborator

Masaryk University

OTHER

collaborator

CZECRIN - Czech Clinical Research Infrastructure Network

UNKNOWN

lead

St. Anne's University Hospital Brno, Czech Republic

OTHER